Algert Global’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.76M | Buy |
1,353,498
+533,472
| +65% | +$3.06M | 0.16% | 195 |
|
|
2025
Q1 | $6.69M | Buy |
820,026
+394,943
| +93% | +$3.22M | 0.17% | 188 |
|
|
2024
Q4 | $4M | Buy |
425,083
+165,923
| +64% | +$1.56M | 0.09% | 354 |
|
|
2024
Q3 | $2.77M | Buy |
259,160
+170,575
| +193% | +$1.82M | 0.07% | 449 |
|
|
2024
Q2 | $879K | Buy |
+88,585
| New | +$879K | 0.03% | 717 |
|
|
2024
Q1 | – | Sell |
-184,540
| Closed | -$2.62M | – | 1139 |
|
|
2023
Q4 | $2.62M | Buy |
+184,540
| New | +$2.62M | 0.11% | 326 |
|
|
2023
Q2 | – | Sell |
-330,425
| Closed | -$3.66M | – | 1139 |
|
|
2023
Q1 | $3.66M | Buy |
330,425
+52,073
| +19% | +$577K | 0.17% | 170 |
|
|
2022
Q4 | $3.4M | Buy |
278,352
+62,440
| +29% | +$762K | 0.19% | 148 |
|
|
2022
Q3 | $2.25M | Buy |
215,912
+164,364
| +319% | +$1.72M | 0.14% | 237 |
|
|
2022
Q2 | $554K | Sell |
51,548
-103,251
| -67% | -$1.11M | 0.04% | 722 |
|
|
2022
Q1 | $1.47M | Buy |
154,799
+108,673
| +236% | +$1.03M | 0.1% | 358 |
|
|
2021
Q4 | $533K | Buy |
46,126
+6,331
| +16% | +$73.2K | 0.07% | 515 |
|
|
2021
Q3 | $380K | Buy |
39,795
+20,541
| +107% | +$196K | 0.05% | 659 |
|
|
2021
Q2 | $186K | Sell |
19,254
-27,874
| -59% | -$269K | 0.06% | 362 |
|
|
2021
Q1 | $466K | Sell |
47,128
-11,340
| -19% | -$112K | 0.15% | 216 |
|
|
2020
Q4 | $1.35M | Buy |
58,468
+26,940
| +85% | +$622K | 0.39% | 91 |
|
|
2020
Q3 | $445K | Sell |
31,528
-45,550
| -59% | -$643K | 0.14% | 209 |
|
|
2020
Q2 | $1.16M | Sell |
77,078
-21,597
| -22% | -$326K | 0.39% | 83 |
|
|
2020
Q1 | $912K | Buy |
+98,675
| New | +$912K | 0.38% | 87 |
|